Taiyen Biotech Co., Ltd. (TPE:1737)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
+0.10 (0.32%)
Apr 29, 2026, 1:30 PM CST
0.47%
Market Cap 6.36B
Revenue (ttm) 3.31B
Net Income (ttm) 399.87M
Shares Out 200.00M
EPS (ttm) 1.99
PE Ratio 15.98
Forward PE n/a
Dividend 1.40 (4.42%)
Ex-Dividend Date Aug 20, 2025
Volume 60,550
Average Volume 116,923
Open 31.90
Previous Close 31.70
Day's Range 31.65 - 31.90
52-Week Range 30.80 - 33.45
Beta 0.16
RSI 48.61
Earnings Date May 5, 2026

About Taiyen Biotech

Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers beauty and skincare, and cleaning products; salt products; and leisure and pet foods, as well as health supplement. The company was founded in 1952 and is based in Tainan City, Taiwan. [Read more]

Founded 1952
Employees 450
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1737
Full Company Profile

Financial Performance

In 2025, Taiyen Biotech's revenue was 3.31 billion, an increase of 2.15% compared to the previous year's 3.24 billion. Earnings were 399.87 million, an increase of 7.63%.

Financial Statements

News

There is no news available yet.